These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20397586)

  • 1. Impact of drug tolerability on the selection of antidepressant treatment in patients with major depressive disorder.
    Ginsberg LD
    CNS Spectr; 2009 Dec; 14(12 Suppl 12):8-14. PubMed ID: 20397586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors impacting the selection of antidepressant treatment in patients with major depressive disorder at risk for nonadherence.
    Shelton C
    CNS Spectr; 2009 Dec; 14(12 Suppl 12):15-9. PubMed ID: 20397587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of contemporary antidepressants: tolerability.
    Papakostas GI
    J Clin Psychiatry; 2007; 68 Suppl 10():11-7. PubMed ID: 17900204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation strategies to increase antidepressant tolerability.
    Zajecka JM
    J Clin Psychiatry; 2007; 68 Suppl 10():23-7. PubMed ID: 17900206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why isn't bupropion the most frequently prescribed antidepressant?
    Zimmerman M; Posternak MA; Attiullah N; Friedman M; Boland RJ; Baymiller S; Berlowitz SL; Rahman S; Uy KK; Singer S; Chelminski I
    J Clin Psychiatry; 2005 May; 66(5):603-10. PubMed ID: 15889947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dysfunction associated with major depressive disorder and antidepressant treatment.
    Clayton AH; El Haddad S; Iluonakhamhe JP; Ponce Martinez C; Schuck AE
    Expert Opin Drug Saf; 2014 Oct; 13(10):1361-74. PubMed ID: 25148932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy, tolerability, and safety of contemporary antidepressants.
    Papakostas GI
    J Clin Psychiatry; 2010; 71 Suppl E1():e03. PubMed ID: 20371030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability issues during long-term treatment with antidepressants.
    Cassano P; Fava M
    Ann Clin Psychiatry; 2004; 16(1):15-25. PubMed ID: 15147109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials.
    Haberfellner EM
    Pharmacopsychiatry; 2007 Sep; 40(5):173-82. PubMed ID: 17874347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sildenafil on quality of life.
    Dording CM; LaRocca RA; Hails KA; Vitolo OV; Wisniewski SR; Balasubramani GK; Trivedi M; Fava M; Mischoulon D
    Ann Clin Psychiatry; 2013 Feb; 25(1):3-10. PubMed ID: 23376864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants.
    Balon R; Segraves RT
    J Sex Marital Ther; 2008; 34(4):353-65. PubMed ID: 18576236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan.
    Chen KC; Yang YK; Lee IH; Yeh TL; Lu RB; Chen PS
    Depress Anxiety; 2008; 25(9):E56-62. PubMed ID: 17551923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trials.
    Khin NA; Kronstein PD; Yang P; Ishida E; Hung HM; Mathis MV; Unger EF; Temple RJ
    J Clin Psychiatry; 2015 Aug; 76(8):1060-3. PubMed ID: 26214346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms of tolerance in antidepressant action.
    Fava GA; Offidani E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1593-602. PubMed ID: 20728491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.
    Möller HJ
    World J Biol Psychiatry; 2008; 9(2):102-14. PubMed ID: 18428079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early weight gain predicts later weight gain in depressed patients treated with antidepressants: Findings from the METADAP cohort.
    Asmar KE; Fève B; Colle R; Gressier F; Vievard A; Trabado S; Verstuyft C; Haffen E; Polosan M; Ferreri F; Falissard B; Chanson P; Becquemont L; Corruble E
    J Affect Disord; 2018 Dec; 241():22-28. PubMed ID: 30092445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders.
    Sun Y; Narayan VA; Wittenberg GM
    BMC Pharmacol Toxicol; 2016 Oct; 17(1):47. PubMed ID: 27765060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance: the impact of adverse events and tolerability on the physician's treatment decisions.
    Roose SP
    Eur Neuropsychopharmacol; 2003 Sep; 13 Suppl 3():S85-92. PubMed ID: 14550581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort.
    El Asmar K; Fève B; Colle R; Trabado S; Verstuyft C; Gressier F; Vievard A; Haffen E; Polosan M; Ferreri F; Falissard B; Chanson P; Becquemont L; Corruble E
    J Psychiatr Res; 2018 Dec; 107():120-127. PubMed ID: 30390577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and drug induced side effects in early versus late antidepressant responders.
    Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
    J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.